Clinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta

Clifford Sample; Robert J Bailey; Dennis Todoruk; Daniel Sadowski; Gramlich Leah; Mario Milan; Raeleen Cherry; Mang Ma; Eoin Lalor; John McKaigney; Richard Sherbaniuk; Kata Matic; Connie Switzer; Fedorak Richard N

doi:10.1155/2002/379307

Canadian Journal of Gastroenterology (Jan 2002)

Clinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta

Clifford Sample,
Robert J Bailey,
Dennis Todoruk,
Daniel Sadowski,
Gramlich Leah,
Mario Milan,
Raeleen Cherry,
Mang Ma,
Eoin Lalor,
John McKaigney,
Richard Sherbaniuk,
Kata Matic,
Connie Switzer,
Fedorak Richard N

Affiliations

Clifford Sample: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Robert J Bailey: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Dennis Todoruk: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Daniel Sadowski: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Gramlich Leah: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Mario Milan: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Raeleen Cherry: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Mang Ma: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Eoin Lalor: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
John McKaigney: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Richard Sherbaniuk: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Kata Matic: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Connie Switzer: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada
Fedorak Richard N: Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

DOI: https://doi.org/10.1155/2002/379307
Journal volume & issue: Vol. 16, no. 3
pp. 165 – 170

Abstract

Read online

OBJECTIVE: To determine whether the clinical efficacy and safety of infliximab in diverse clinical referral practices was similar to that seen in the randomized, controlled clinical trials.

Published in Canadian Journal of Gastroenterology

ISSN: 0835-7900 (Print); 1916-7237 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: https://onlinelibrary.wiley.com/journal/1720

About the journal